


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app17.us.archive.org';v.server_ms=1005;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>ACR Appropriateness Criteria&amp;reg; sudden onset of cold, painful leg. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180713043816im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180713043816im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180713043816im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180713043816im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180713043816/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180713043816im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180713043816cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180713043816js_/https://dap.digitalgov.gov/Universal足-Federated-足Analytics-足Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180713043816if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180713043816/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180713043816if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180713043816/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180713043816/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180713043816/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180713043816/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180713043816im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180713043816im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180713043816im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180713043816/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180713043816/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180713043816/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180713043816/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180713043816/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180713043816/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180713043816/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180713043816/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180713043816/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180713043816/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180713043816/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180713043816/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180713043816/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180713043816/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180713043816/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180713043816/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180713043816/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180713043816/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180713043816/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180713043816/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180713043816/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:011037</li>
            <li>2016
            </li>            
                                </ul>
        <div>
                <h1>ACR Appropriateness Criteria&reg; sudden onset of cold, painful leg.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180713043816/https://www.guideline.gov/search?f_Guideline_Developer_String=American%20College%20of%20Radiology&amp;fLockTerm=American%2BCollege%2Bof%2BRadiology">American College of Radiology</a></li>
                        <li>   
                                <a id="246" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Weiss CR, Azene EM, Majdalany BS, AbuRahma AF, Collins JD, Francois CJ, Gerhard-Herman MD, Gornik HL, Moriarty JM, Norton PT, Ptak T, Reis SP, Rybicki FJ, Kalva SP, Expert Panel on Vascular Imaging. ACR Appropriateness Criteria速 sudden onset of cold, painful leg. Reston (VA): American College of Radiology (ACR); 2016. 8 p.  [55 references]</td></tr></table>                    <p><a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=fulltextlink&amp;redirect=https%253a%252f%252facsearch.acr.org%252fdocs%252f69338%252fNarrative">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Weiss C, Azene E, Rybicki FJ, Kim HS, Desjardins B, Fan CM, Flamm SD, Francois CJ, Gerhard-Herman MD, Kalva SP, Mansour MA, Mohler ER III, Oliva IB, Schenker MP, Expert Panel on Vascular Imaging. ACR Appropriateness Criteria&reg; sudden onset of cold, painful leg. [online publication]. Reston (VA): American College of Radiology (ACR); 2012. 6 p. [50 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                            <h4>UMLS Concepts <a href="/web/20180713043816/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180713043816/https://www.guideline.gov/search?f_ICD9CM_CUI=C0340589&amp;fLockTerm=Arterial+embolism+and+thrombosis+of+lower+extremity">Arterial embolism and thrombosis of lower extremity</a>
 (444.22), <a href="/web/20180713043816/https://www.guideline.gov/search?f_ICD9CM_CUI=C0011923&amp;fLockTerm=Diagnostic+imaging%2c+not+elsewhere+classified">Diagnostic imaging, not elsewhere classified</a>
 (88.90)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0001314&amp;fLockTerm=Acute+Disease">Acute Disease</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0002978&amp;fLockTerm=Angiography">Angiography</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0003838&amp;fLockTerm=Arterial+Occlusive+Diseases">Arterial Occlusive Diseases</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0011906&amp;fLockTerm=Diagnosis%2c+Differential">Diagnosis, Differential</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0011923&amp;fLockTerm=Diagnostic+Imaging">Diagnostic Imaging</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0022116&amp;fLockTerm=Ischemia">Ischemia</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0243032&amp;fLockTerm=Magnetic+Resonance+Angiography">Magnetic Resonance Angiography</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0040046&amp;fLockTerm=Thrombophlebitis">Thrombophlebitis</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0936234&amp;fLockTerm=Tomography+Scanners%2c+X-Ray+Computed">Tomography Scanners, X-Ray Computed</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0040405&amp;fLockTerm=Tomography%2c+X-Ray+Computed">Tomography, X-Ray Computed</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MSH_CUI=C0242845&amp;fLockTerm=Ultrasonography%2c+Doppler%2c+Duplex">Ultrasonography, Doppler, Duplex</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0002978&amp;fLockTerm=angiogram">angiogram</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0003838&amp;fLockTerm=Arterial+Occlusive+Diseases">Arterial Occlusive Diseases</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0936234&amp;fLockTerm=Computed+Tomography+Scanning+Systems">Computed Tomography Scanning Systems</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0011923&amp;fLockTerm=Diagnostic+Imaging">Diagnostic Imaging</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0043299&amp;fLockTerm=Diagnostic+radiologic+examination">Diagnostic radiologic examination</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0011906&amp;fLockTerm=Differential+Diagnosis">Differential Diagnosis</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0022116&amp;fLockTerm=Ischemia">Ischemia</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0243032&amp;fLockTerm=Magnetic+Resonance+Angiography">Magnetic Resonance Angiography</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0023222&amp;fLockTerm=Pain+in+lower+limb">Pain in lower limb</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0040046&amp;fLockTerm=Thrombophlebitis">Thrombophlebitis</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_MTH_CUI=C0040405&amp;fLockTerm=X-Ray+Computed+Tomography">X-Ray Computed Tomography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180713043816/https://www.guideline.gov/search?f_PDQ_CUI=C0002978&amp;fLockTerm=angiography">angiography</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_PDQ_CUI=C0040405&amp;fLockTerm=computed+tomography">computed tomography</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_PDQ_CUI=C0011923&amp;fLockTerm=diagnostic+imaging">diagnostic imaging</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_PDQ_CUI=C0043299&amp;fLockTerm=diagnostic+radiology">diagnostic radiology</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0001314&amp;fLockTerm=Acute+disease">Acute disease</a>
 (2704003), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0002978&amp;fLockTerm=Angiography">Angiography</a>
 (77343006), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0003844&amp;fLockTerm=Arteriography">Arteriography</a>
 (129118002), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0040405&amp;fLockTerm=Computerized+axial+tomography">Computerized axial tomography</a>
 (77477000), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009924&amp;fLockTerm=Contrast+media">Contrast media</a>
 (385420005), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009924&amp;fLockTerm=Contrast+media">Contrast media</a>
 (407935004), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0340566&amp;fLockTerm=Critical+lower+limb+ischemia">Critical lower limb ischemia</a>
 (233962007), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1629855&amp;fLockTerm=CT+angiography+of+lower+limb+artery">CT angiography of lower limb artery</a>
 (419089004), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0412642&amp;fLockTerm=CT+of+lower+limb">CT of lower limb</a>
 (241570001), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C3840192&amp;fLockTerm=CT+of+lower+limb+with+contrast">CT of lower limb with contrast</a>
 (702502001), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011906&amp;fLockTerm=Differential+diagnosis">Differential diagnosis</a>
 (47965005), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0242845&amp;fLockTerm=Duplex+ultrasound">Duplex ultrasound</a>
 (312236008), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011923&amp;fLockTerm=Imaging">Imaging</a>
 (363679005), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0022116&amp;fLockTerm=Ischemia">Ischemia</a>
 (52674009), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0243032&amp;fLockTerm=Magnetic+resonance+imaging+(MRI)+of+vessels">Magnetic resonance imaging (MRI) of vessels</a>
 (241663008), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0336660&amp;fLockTerm=Magnetic+resonance+imaging+unit">Magnetic resonance imaging unit</a>
 (90003000), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0412711&amp;fLockTerm=MRI+of+lower+extremity">MRI of lower extremity</a>
 (113109007), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C3839302&amp;fLockTerm=MRI+of+lower+limb+with+contrast">MRI of lower limb with contrast</a>
 (702719002), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C2317045&amp;fLockTerm=Occlusive+disease+of+artery+of+lower+extremity">Occlusive disease of artery of lower extremity</a>
 (432083006), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0564822&amp;fLockTerm=Pain+in+left+lower+limb">Pain in left lower limb</a>
 (287047008), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0023222&amp;fLockTerm=Pain+in+lower+limb">Pain in lower limb</a>
 (10601006), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0564823&amp;fLockTerm=Pain+in+right+lower+limb">Pain in right lower limb</a>
 (287048003), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0238367&amp;fLockTerm=Phlegmasia+cerulea+dolens">Phlegmasia cerulea dolens</a>
 (66877004), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0040046&amp;fLockTerm=Thrombophlebitis">Thrombophlebitis</a>
 (64156001), <a href="/web/20180713043816/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0412528&amp;fLockTerm=US+scan+of+lower+limb+vessels">US scan of lower limb vessels</a>
 (241464005)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SPN</h5>
                    <div class="field-content">
<a href="/web/20180713043816/https://www.guideline.gov/search?f_SPN_CUI=C0336660&amp;fLockTerm=SYSTEM%2c+NUCLEAR+MAGNETIC+RESONANCE+IMAGING">SYSTEM, NUCLEAR MAGNETIC RESONANCE IMAGING</a>
, <a href="/web/20180713043816/https://www.guideline.gov/search?f_SPN_CUI=C0936234&amp;fLockTerm=SYSTEM%2c+X-RAY%2c+TOMOGRAPHY%2c+COMPUTED">SYSTEM, X-RAY, TOMOGRAPHY, COMPUTED</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180713043816/https://www.guideline.gov/search?f_UMD_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
 (16-573), <a href="/web/20180713043816/https://www.guideline.gov/search?f_UMD_CUI=C0936234&amp;fLockTerm=Scanning+Systems%2c+Computed+Tomography">Scanning Systems, Computed Tomography</a>
 (13-469), <a href="/web/20180713043816/https://www.guideline.gov/search?f_UMD_CUI=C0336660&amp;fLockTerm=Scanning+Systems%2c+Magnetic+Resonance+Imaging">Scanning Systems, Magnetic Resonance Imaging</a>
 (16-260), <a href="/web/20180713043816/https://www.guideline.gov/search?f_UMD_CUI=C0183139&amp;fLockTerm=Scanning+Systems%2c+Ultrasonic%2c+Vascular">Scanning Systems, Ultrasonic, Vascular</a>
 (15-957)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#430" class="section-mark">Contraindications</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180713043816/https://www.guideline.gov/summaries/downloadcontent/ngc-11037?contentType=pdf" class="pdf">.PDF 116.5 kb</a></li>
                            <li><a href="/web/20180713043816/https://www.guideline.gov/summaries/downloadcontent/ngc-11037?contentType=word" class="word">Word Document 316.9 kb</a></li>
                            <li><a href="/web/20180713043816/https://www.guideline.gov/summaries/downloadcontent/ngc-11037?contentType=xml" class="xml">.XML 60.0 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180713043816/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/50430/acr-appropriateness-criteria--sudden-onset-of-cold-painful-leg" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180713043816/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/50430/acr-appropriateness-criteria--sudden-onset-of-cold-painful-leg" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180713043816/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/50430/acr-appropriateness-criteria--sudden-onset-of-cold-painful-leg&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180713043816/mailto:/?Subject=AHRQ: ACR Appropriateness Criteria&amp;amp;reg; sudden onset of cold, painful leg.&amp;body=https://www.guideline.gov/summaries/summary/50430/acr-appropriateness-criteria--sudden-onset-of-cold-painful-leg" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: ACR Appropriateness Criteria&reg; sudden onset of cold, painful leg. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2016 Jan 01. [cited 2018 Jul 13]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180713043816/https://www.guideline.gov/summaries/citedownload/50430?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180713043816/https://www.guideline.gov/summaries/citedownload/50430?format=enw">EndNote</a></li>
                            <li><a href="/web/20180713043816/https://www.guideline.gov/summaries/citedownload/50430?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180713043816/https://www.guideline.gov/summaries/citedownload/50430?format=txt">Medlars</a></li>
                            <li><a href="/web/20180713043816/https://www.guideline.gov/summaries/citedownload/50430?format=ris">ProCite</a></li>
                            <li><a href="/web/20180713043816/https://www.guideline.gov/summaries/citedownload/50430">RefWorks</a></li>
                            <li><a href="/web/20180713043816/https://www.guideline.gov/summaries/citedownload/50430?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="50430" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>ACR Appropriateness Criteria&reg;</strong></p>
<p><strong><span style="text-decoration: underline;">Clinical Condition</span>: Sudden Onset of Cold, Painful Leg</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Sudden Onset of Cold, Painful Leg">
    <thead>
        <tr>
            <th width="30%" valign="top" style="font-weight: bold; text-align: center;" scope="col">Radiologic Procedure</th>
            <th width="15%" valign="top" style="font-weight: bold; text-align: center;" scope="col">Rating</th>
            <th width="40%" valign="top" style="font-weight: bold; text-align: center;" scope="col">Comments</th>
            <th width="25%" valign="top" style="font-weight: bold; text-align: center;" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">Arteriography lower extremity </td>
            <td valign="top" style="text-align: center;">8</td>
            <td valign="top">This procedure is the preferred option if clinical suspicion of acute arterial obstruction is intermediate to high.</td>
            <td valign="top" style="text-align: center;"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CTA lower extremity with IV contrast</td>
            <td valign="top" style="text-align: center;">7</td>
            <td valign="top">Consider in place of arteriography if clinical suspicion of arterial obstruction is low and patient has a stable baseline eGFR &ge;45 mL/min.</td>
            <td valign="top" style="text-align: center;"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">MRA lower extremity without and with IV contrast</td>
            <td valign="top" style="text-align: center;">7</td>
            <td valign="top">This procedure may help reduce total contrast dose. Consider prior to arteriography in patients with mild to moderate chronic kidney disease (GFR 30&ndash;89 mL/min).</td>
            <td valign="top" style="text-align: center;">O</td>
        </tr>
        <tr>
            <td valign="top">MRA lower extremity without IV contrast</td>
            <td valign="top" style="text-align: center;">5</td>
            <td valign="top">This procedure should be considered in patients with eGFR &lt;30 mL/min who are not yet on dialysis.</td>
            <td valign="top" style="text-align: center;">O</td>
        </tr>
        <tr>
            <td valign="top">US duplex Doppler lower extremity</td>
            <td valign="top" style="text-align: center;">5</td>
            <td valign="top">This procedure may be helpful for problem solving or targeted examinations (e.g., bypass graft).</td>
            <td valign="top" style="text-align: center;">O</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th valign="top" style="font-weight: bold; text-align: center;" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th valign="top" style="font-weight: bold; text-align: center;">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the table are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Summary of Literature Review</span></strong></p>
<p><strong>Introduction/Background</strong></p>
<p>Acute onset of a cold painful leg, also known as acute limb ischemia (ALI), although not directly a significant cause of mortality, contributes significantly to morbidity. The etiologies are limited, the most common being arterial occlusion. Total venous outflow occlusion is another but much less common cause. It often results in what is known clinically as "phlegmasia cerulea dolens" (precursor to venous gangrene), with lower-extremity swelling, pain, and a dusky color. It is differentiated from arterial occlusion by the presence of distal arterial pulses. Other causes, such as prolonged exposure to cold and trauma, are rare and usually clinically obvious.</p>
<p>ALI generally requires urgent treatment. Appropriate care of the patient requires assessing the source (i.e., embolic versus thrombotic occlusion) and extent of the underlying arterial obstruction. The available diagnostic studies include invasive catheter angiography and noninvasive testing. Noninvasive imaging modalities include duplex ultrasound (US), magnetic resonance angiography (MRA), and computed tomography angiography (CTA).</p>
<p>The published literature on imaging of peripheral artery disease (PAD) focuses almost exclusively on patients with chronic PAD. This includes asymptomatic PAD, leg pain with exertion (i.e., intermittent claudication), and critical limb ischemia (CLI, defined as chronic leg or foot pain at rest, skin ulceration, or gangrene). By comparison, the literature focused on imaging patients with ALI is very limited. Consequently, the following discussion relies heavily on studies of patients with chronic PAD.</p>
<p><strong>Arteriography</strong></p>
<p>Arteriography (digital subtraction angiography [DSA]) performed with iodinated contrast material remains the diagnostic gold standard for detecting peripheral vascular occlusive disease. However, new and less invasive modalities are gradually replacing it. The ability to diagnose and treat disease in a single procedure is a major benefit of DSA that remains unmatched in the treatment of acute ischemic vascular disease. There has been extensive debate regarding the cost-benefit ratios when comparing DSA and MRA. Because of the invasive character of DSA, there is a recovery period typically lasting 4 hours or more. In some countries, patients remain in the hospital overnight. If complications from DSA occur, additional intervention and prolongation of the hospital stay may add cost as well as morbidity or even mortality. To be truly cost effective, any noninvasive method would have to supplant DSA, not just precede or supplement it.</p>
<p>The reported incidence of complications with DSA varies greatly. There are also risks associated with iodinated contrast materials. Most worrisome are the rare fatal systemic reactions and contrast-induced nephropathy. The nephrotoxic effects are important to consider as many patients who present with the sudden onset of a cold, painful leg are elderly, diabetic, and have impaired renal function. Carbon dioxide angiography or other imaging modalities that do not use iodinated contrast material should be considered in patients with estimated glomerular filtration rate (eGFR) &lt;45 mL/min/1.73 m<sup>2</sup>. Also, many patients will have repeated catheter angiography over the course of their disease, and minimizing patient radiation exposure should always be considered. Angiography has also been criticized for its imperfect evaluation of outflow vessels, specifically for limited visualization of pedal vasculature and patent distal vessels beyond significant obstructive lesions.</p>
<p><strong>Magnetic Resonance Angiography</strong></p>
<p>MRA has high sensitivity and specificity for detecting arterial occlusive disease, using DSA as a gold standard. Early imaging protocols required 30 minutes or more of acquisition time. However, recent advances, including 3T magnetic fields, parallel imaging, multichannel coils, sequences such as time-resolved MRA, and enhanced acquisition speed, enable rapid assessment of ALI. In addition to decreased total examination times, faster acquisition reduces motion artifact and venous contamination. Motion artifact can also be corrected with automated image registration protocols. Improved spatial resolution translates to thinner slices and clearer depiction of small vessels. Most information needed for the interventional radiologist or vascular surgeon is routinely illustrated with MRA, such as a general road map of arterial anatomy, including runoff vessels and collaterals, as well as the location and extent of significant stenoses and occlusions.</p>
<p>Limitations include less accurate evaluation of smaller arteries, which means that more time-consuming sequences are required to get better results. Also, limited information can currently be obtained on a routine basis regarding the character of vessel walls and detailed flow dynamics, although time-resolved contrast-enhanced MRA techniques are beginning to provide qualitative flow information. Overestimation of stenosis has been reported in native arteries and in patients with vascular stents secondary to artifacts. Overestimation in native arteries varies among sequences and may or may not be a clinical problem in specific cases. This uncertainty highlights the poor consensus on optimal protocols. In part, this is a function of the continuing evolution of technology, both software and hardware.</p>
<p>Another concern with MRA is that most techniques have required the administration of a gadolinium-based contrast agent. However, MRA has few associated complications, with the realization of the risk of nephrogenic systemic fibrosis (NSF) in patients with underlying renal dysfunction who receive these contrast materials. There has been increased interest in using other modalities or limiting the use of gadolinium-based contrast material in such patients. Significantly lower contrast doses can be used at 3T compared to 1.5T without compromising image quality. Noncontrast MRA may prove useful. However, further improvements will be required, particularly in techniques for assessing pedal circulation. Finally, blood-pool gadolinium-chelate contrast agents have prolonged retention in the intravascular space and allow for steady-state imaging that, in turn, can enable high spatial resolution acquisitions. Additional studies will be needed to confirm potential clinical benefits and cost-effectiveness of such agents.</p>
<p><strong>Computed Tomography Angiography</strong></p>
<p>Multidetector-row technology has dramatically shortened CT acquisition times, improved spatial resolution, and improved vascular image quality depicted with CT. Multidetector CT (MDCT) scanners can image from the diaphragm to the ankles in &lt;30 seconds using a single-contrast bolus. The use of 64-row or greater MDCT significantly increases the accuracy of stenosis detection, particularly in smaller vessels. Dynamic, time-resolved "4-D" CTA may improve accuracy even further. However, additional studies are needed before this can be confirmed.</p>
<p>Sophisticated postprocessing tools enable multiplanar visualization in all 3 orthogonal axes as well as in any oblique axis. In addition to multiplanar reconstructions, both volume rendering and maximum-intensity projections can be used, each with advantages and disadvantages. Maximum-intensity projections are very accurate for larger vessels (as distal as the infrapopliteal region) but less accurate for smaller vessels. Volume rendering, including endoluminal reconstruction, is good for evaluating embolic or vascular endothelial injury. It is also valuable in evaluating heavily calcified vessels. However, interpretation from volume-rendered images or maximum-intensity projections alone is insufficient to characterize vascular lesions and should always be accompanied by an assessment of the raw axial dataset and multiplanar reformatted images.</p>
<p>CTA has proven comparably accurate to MRA in evaluating peripheral arterial diseases. The advantages of CTA over MRA are its excellent spatial resolution, widespread availability, cost-effectiveness, and usability in patients who have contraindications to MRI, such as those who have pacemakers or defibrillators.</p>
<p>One disadvantage of CTA is the limited ability to depict the lumen in heavily calcified arteries. Calcium-induced artifact causes an overestimation of stenosis. In theory, dual-energy or spectral CTA can provide image reconstructions at various x-ray energy levels and can be used to distinguish between vascular calcium and iodinated contrast material. Initial studies have shown improved accuracy of stenosis detection and grading with dual-energy CTA compared to conventional CTA. However, early studies also suggest dual-energy CTA may still overestimate high-grade vessel stenosis as occlusion. Dual-energy CTA may also correlate less well with DSA in calcified calf and pedal arteries. Expanded clinical use of dual-energy CTA will require further validation and assessment of relative radiation doses.</p>
<p>Complications related to iodinated contrast are similar to those in catheter-based angiography and have been discussed above. Cumulative radiation dose is also a concern; CTA has been increasingly used for both preprocedural planning and postprocedure surveillance. Recent advances in hardware and software, however, have achieved lower radiation dosages for a single CTA examination. Also, techniques tailored to the evaluation of lower-limb vasculature have been published that allow reduced patient radiation by decreasing kVp, while preserving the ability to evaluate the smaller lower-limb vessels. Decreasing kVp also has the added advantage of allowing lower doses of iodinated contrast as kVp approaches the iodine K-edge.</p>
<p><strong>Ultrasound Duplex Doppler</strong></p>
<p>In this patient population, duplex US is limited by the need for operator expertise, by poor accessibility of vessels, by heavy calcification, and often by poor overall accuracy if multilevel disease is present. Its advantages are that it can provide useful physiologic as well as anatomic information. Further, it is noninvasive, widely available, and relatively inexpensive.</p>
<p><strong>Echocardiography</strong></p>
<p>Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) are generally not part of the initial workup but may be useful if patient symptoms could be from cardiac embolization, particularly in patients with known atrial fibrillation. TEE is more invasive and time-consuming than TTE but affords better visualization of the left atrium. TEE may be useful to look for sources of emboli when TTE is indeterminate.</p>
<p>In the acute setting, however, this knowledge is unlikely to influence the immediate evaluation. Similarly, cardiac CT or MRI may identify or exclude cardiac thrombus or areas of cardiac dysfunction that might be the source of emboli, but this knowledge is not likely to have clinical impact in the acute setting.</p>
<p><strong>Noninvasive Physiologic Testing</strong></p>
<p>Noninvasive physiologic testing includes measurement of ankle-brachial index (ABI), segmental blood pressures, Doppler waveforms, handheld Doppler, pulse-volume recordings, transcutaneous oxygen pressure measurement (TcPO<sub>2</sub>), and exercise treadmill testing. Segmental studies, TcPO<sub>2</sub>, and exercise treadmill testing are of little use in the diagnosis and management of ALI. However, ABI measurement and handheld Doppler are simple, rapid, and reliable methods to confirm arterial occlusion as the etiology of sudden onset of cold leg when the cause is not obvious. Both ABI and handheld Doppler can also serve as objective baseline tests to follow the patient after intervention. Useful physiologic information may also be obtained. In this clinical setting, other noninvasive tests generally are not helpful as they do not provide specific information that will alter or guide therapy.</p>
<p><strong>Summary</strong></p>
<ul style="list-style-type: disc;">
    <li>Arteriography (DSA) remains the gold standard for diagnosing acute limb ischemia and continues to be the only modality that allows diagnosis and simultaneous treatment of pathology. This advantage alone will ensure that it continues to be a valuable tool. </li>
    <li>Noninvasive imaging with MRA or CTA before arteriography (DSA) or surgery is accepted and common. Both MRA and CTA can be used for diagnosis and may help surgical or interventional planning. </li>
    <li>Other imaging and noninvasive physiologic testing may prove important for longer-term management but are less recommended in the acute setting. </li>
</ul>
<p><strong>Abbreviations</strong></p>
<ul style="list-style-type: disc;">
    <li>CTA, computed tomography angiography </li>
    <li>eGFR, estimated glomerular filtration rate </li>
    <li>GFR, glomerular filtration rate </li>
    <li>IV, intravenous </li>
    <li>MRA, magnetic resonance angiography </li>
    <li>US, ultrasound </li>
</ul>
<p><strong>Relative Radiation Level Designations</strong></p>
<table width="50%" border="1" cellspacing="3" cellpadding="5" summary="Table: Relative Radiation Level Designations">
    <thead>
        <tr>
            <th valign="top" style="font-weight: bold; text-align: center;">Relative Radiation Level*</th>
            <th valign="top" style="font-weight: bold; text-align: center;">Adult Effective Dose Estimate Range</th>
            <th valign="top" style="font-weight: bold; text-align: center;">Pediatric Effective Dose Estimate Range</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top" style="text-align: center;">O</td>
            <td valign="top" style="text-align: center;">0 mSv</td>
            <td valign="top" style="text-align: center;">0 mSv</td>
        </tr>
        <tr>
            <td valign="top" style="text-align: center;"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td valign="top" style="text-align: center;">&lt;0.1 mSv</td>
            <td valign="top" style="text-align: center;">&lt;0.03 mSv</td>
        </tr>
        <tr>
            <td valign="top" style="text-align: center;"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td valign="top" style="text-align: center;">0.1-1 mSv</td>
            <td valign="top" style="text-align: center;">0.03-0.3 mSv</td>
        </tr>
        <tr>
            <td valign="top" style="text-align: center;"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td valign="top" style="text-align: center;">1-10 mSv</td>
            <td valign="top" style="text-align: center;">0.3-3 mSv</td>
        </tr>
        <tr>
            <td valign="top" style="text-align: center;"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td valign="top" style="text-align: center;">10-30 mSv</td>
            <td valign="top" style="text-align: center;">3-10 mSv</td>
        </tr>
        <tr>
            <td valign="top" style="text-align: center;"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 5" src="https://web.archive.org/web/20180713043816im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td valign="top" style="text-align: center;">30-100 mSv</td>
            <td valign="top" style="text-align: center;">10-30 mSv</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <td valign="top" colspan="3">*RRL assignments for some of the examinations cannot be made, because the actual patient doses in these procedures vary as a function of a number of factors (e.g., region of the body exposed to ionizing radiation, the imaging guidance that is used). The RRLs for these examinations are designated as "Varies."</td>
    </tr>
    </tfoot>
</table></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>Algorithms were not developed from criteria guidelines.</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Sudden onset of cold, painful leg</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Diagnosis</p>
                    <p>Evaluation</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Emergency Medicine</p>
                    <p>Family Practice</p>
                    <p>Internal Medicine</p>
                    <p>Radiology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Health Plans</p>
                    <p>Hospitals</p>
                    <p>Managed Care Organizations</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                    <p>Students</p>
                    <p>Utilization Management</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To evaluate the appropriateness of imaging procedures for sudden onset of cold, painful leg</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Patients with sudden onset of cold, painful leg</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><ol style="list-style-type: decimal;">
    <li>Arteriography, lower extremity </li>
    <li>Computed tomography angiography (CTA), lower extremity with intravenous (IV) contrast </li>
    <li>Magnetic resonance angiography (MRA), lower extremity
    <ul style="list-style-type: disc;">
        <li>Without and with IV contrast </li>
        <li>Without IV contrast </li>
    </ul>
    </li>
    <li>Ultrasound (US), lower extremity, duplex Doppler </li>
</ol></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Utility of imaging and physiologic testing procedures in differential diagnosis </li>
    <li>Sensitivity, specificity, accuracy, and diagnostic performance of imaging and physiologic testing procedures in the assessment of lower extremity arterial disease </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Literature Search Summary</span></strong></p>
<p>Of the 50 citations in the original bibliography, 45 were retained in the final document. Articles were removed from the original bibliography if they were more than 10 years old and did not contribute to the evidence or they were no longer cited in the revised narrative text.</p>
<p>A new literature search was conducted in May 2015 to identify additional evidence published since the <em>ACR Appropriateness Criteria&reg; Sudden Onset of Cold, Painful Leg</em> topic was finalized. Using the search strategy described in the literature search companion (see the "Availability of Companion Documents" field), 221 articles were found. Eight articles were added to the bibliography. Two hundred thirteen articles were not used due to either poor study design, the articles were not relevant or generalizable to the topic, the results were unclear, misinterpreted, or biased, or the articles were already cited in the original bibliography.</p>
<p>The author added 1 citation from bibliographies, Web sites, or books that were not found in the new literature search.</p>
<p>One citation is a supporting document that was added by staff.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Of the 50 citations in the original bibliography, 45 were retained in the final document. The new literature search conducted in May 2015 identified 8 articles that were added to the bibliography. The author added 1 citation from bibliographies, Web sites, or books that were not found in the new literature search. One citation is a supporting document that was added by staff.</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Definitions of Study Quality Categories</span></strong></p>
<p>Category 1 - The study is well-designed and accounts for common biases.</p>
<p>Category 2 - The study is moderately well-designed and accounts for most common biases.</p>
<p>Category 3 - The study has important study design limitations.</p>
<p>Category 4 - The study or source is not useful as primary evidence. The article may not be a clinical study, the study design is invalid, or conclusions are based on expert consensus.</p>
<p class="Indent">The study does not meet the criteria for or is not a hypothesis-based clinical study (e.g., a book chapter or case report or case series description);</p>
<p class="Indent"><em>Or</em></p>
<p class="Indent">The study may synthesize and draw conclusions about several studies such as a literature review article or book chapter but is not primary evidence;</p>
<p class="Indent"><em>Or</em></p>
<p class="Indent">The study is an expert opinion or consensus document.</p>
<p>Category M - Meta-analysis studies are not rated for study quality using the study element method because the method is designed to evaluate individual studies only. An "M" for the study quality will indicate that the study quality has not been evaluated for the meta-analysis study.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Review of Published Meta-Analyses</p>
                    <p>Systematic Review with Evidence Tables</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>The topic author assesses the literature then drafts or revises the narrative summarizing the evidence found in the literature. American College of Radiology (ACR) staff drafts an evidence table based on the analysis of the selected literature. These tables rate the study quality for each article included in the narrative.</p>
<p>The expert panel reviews the narrative, evidence table and the supporting literature for each of the topic-variant combinations and assigns an appropriateness rating for each procedure listed in the variant table(s). Each individual panel member assigns a rating based on his/her interpretation of the available evidence.</p>
<p>More information about the evidence table development process can be found in the ACR Appropriateness Criteria&reg; Evidence Table Development document (see the "Availability of Companion Documents" field).</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus (Delphi)</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Rating Appropriateness</span></strong></p>
<p>The American College of Radiology (ACR) Appropriateness Criteria (AC) methodology is based on the RAND Appropriateness Method. The appropriateness ratings for each of the procedures or treatments included in the AC topics are determined using a modified Delphi method. A series of surveys are conducted to elicit each panelist's expert interpretation of the evidence, based on the available data, regarding the appropriateness of an imaging or therapeutic procedure for a specific clinical scenario. The expert panel members review the evidence presented and assess the risks or harms of doing the procedure balanced with the benefits of performing the procedure. The direct or indirect costs of a procedure are not considered as a risk or harm when determining appropriateness. When the evidence for a specific topic and variant is uncertain or incomplete, expert opinion may supplement the available evidence or may be the sole source for assessing the appropriateness.</p>
<p>The appropriateness is represented on an ordinal scale that uses integers from 1 to 9 grouped into three categories: 1, 2, or 3 are in the category "usually not appropriate" where the harms of doing the procedure outweigh the benefits; and 7, 8, or 9 are in the category "usually appropriate" where the benefits of doing a procedure outweigh the harms or risks. The middle category, designated "may be appropriate," is represented by 4, 5, or 6 on the scale. The middle category is when the risks and benefits are equivocal or unclear, the dispersion of the individual ratings from the group median rating is too large (i.e., disagreement), the evidence is contradictory or unclear, or there are special circumstances or subpopulations which could influence the risks or benefits that are embedded in the variant.</p>
<p>The ratings assigned by each panel member are presented in a table displaying the frequency distribution of the ratings without identifying which members provided any particular rating. To determine the panel's recommendation, the rating category that contains the median group rating without disagreement is selected. This may be determined after either the first or second rating round. If there is disagreement after the second rating round, the recommendation is "May be appropriate."</p>
<p>This modified Delphi method enables each panelist to articulate his or her individual interpretations of the evidence or expert opinion without excessive influence from fellow panelists in a simple, standardized, and economical process. For additional information on the ratings process see the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRatingRoundInfo.pdf" title="ACR Web site">Rating Round Information</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> document.</p>
<p>Additional methodology documents, including a more detailed explanation of the complete topic development process and all ACR AC topics can be found on the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2fQuality-Safety%2fAppropriateness-Criteria" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> (see also the "Availability of Companion Documents" field).</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p>Not applicable</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>There has been extensive debate regarding the cost-benefit ratios when comparing digital subtraction angiography (DSA) and magnetic resonance angiography (MRA). Because of the invasive character of DSA, there is a recovery period typically lasting 4 hours or more. In some countries, patients remain in the hospital overnight. If complications from DSA occur, additional intervention and prolongation of the hospital stay may add cost as well as morbidity or even mortality. To be truly cost-effective, any noninvasive method would have to supplant DSA, not just precede or supplement it. </li>
    <li>The advantages of computed tomography angiography (CTA) over MRA are its excellent spatial resolution, widespread availability, cost-effectiveness, and usability in patients who have contraindications to magnetic resonance imaging (MRI), such as those who have pacemakers or defibrillators. </li>
</ul></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>Criteria developed by the Expert Panels are reviewed by the American College of Radiology (ACR) Committee on Appropriateness Criteria.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The recommendations are based on analysis of the current medical evidence literature and the application of the RAND/UCLA appropriateness method and expert panel consensus.</p>
<p><strong><span style="text-decoration: underline;">Summary of Evidence</span></strong></p>
<p>Of the 55 references cited in the <em>ACR Appropriateness Criteria&reg; Sudden Onset Cold, Painful Leg</em> document, 48 are categorized as diagnostic references including 11 well designed studies, 22 good quality studies, and 8 quality studies that may have design limitations. Additionally, 4 references are categorized as therapeutic references including 1 good quality study, and 2 quality studies that may have design limitations. There are 8 references that may not be useful as primary evidence. There are 3 references that are meta-analysis studies.</p>
<p>While there are references that report on studies with design limitations, 34 well designed or good quality studies provide good evidence.</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>The ability to diagnose and treat disease in a single procedure is a major benefit of digital subtraction angiography (DSA) that remains unmatched in the treatment of acute ischemic vascular disease.</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Because of the invasive character of digital subtraction angiography (DSA), there is a recovery period typically lasting 4 hours or more. In some countries, patients remain in the hospital overnight. If complications from DSA occur, additional intervention and prolongation of the hospital stay may add cost as well as morbidity or even mortality. </li>
    <li>The reported incidence of complications with DSA varies greatly. There are also risks associated with iodinated contrast materials. Most worrisome are the rare fatal systemic reactions and contrast-induced nephropathy (CIN). The nephrotoxic effects of DSA are important to consider, as many patients who present with the sudden onset of a cold, painful leg are elderly, diabetic, and have impaired renal function. Also, many patients will have repeated catheter angiography over the course of their disease, and minimizing patient radiation exposure should always be considered. </li>
    <li>Cumulative radiation dose is also a concern with computed tomography angiography (CTA); CTA has been increasingly used for both preprocedural planning and postprocedural surveillance. </li>
</ul>
<p><strong><span style="text-decoration: underline;">Relative Radiation Level Information</span></strong></p>
<p>Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level (RRL) indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Patients in the pediatric age group are at inherently higher risk from exposure, both because of organ sensitivity and longer life expectancy (relevant to the long latency that appears to accompany radiation exposure). For these reasons, the RRL dose estimate ranges for pediatric examinations are lower as compared to those specified for adults. Additional information regarding radiation dose assessment for imaging examinations can be found in the ACR Appropriateness Criteria&reg; Radiation Dose Assessment Introduction document (see the "Availability of Companion Documents" field).</p></p>

            </div>
                <h2 id="430" class="accordion-title section-430 is-active" role="tab" aria-expanded="true"><a href="#">Contraindications</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Contraindications</a></h3>
                    <p><div class="content_para"><p>Magnetic resonance imaging (MRI) is contraindicated in patients with pacemakers or defibrillators in place.</p></div></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>The American College of Radiology (ACR) Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists, and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient's clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient's condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the U.S. Food and Drug Administration (FDA) have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination. </li>
    <li>ACR seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply individual or society endorsement of the final document. </li>
</ul></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Getting Better</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Weiss CR, Azene EM, Majdalany BS, AbuRahma AF, Collins JD, Francois CJ, Gerhard-Herman MD, Gornik HL, Moriarty JM, Norton PT, Ptak T, Reis SP, Rybicki FJ, Kalva SP, Expert Panel on Vascular Imaging. ACR Appropriateness Criteria速 sudden onset of cold, painful leg. Reston (VA): American College of Radiology (ACR); 2016. 8 p.  [55 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2016</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>American College of Radiology - Medical Specialty Society</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>The American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria&reg;.</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Committee on Appropriateness Criteria, Expert Panel on Vascular Imaging</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Panel Members</em>: Clifford R. Weiss, MD (<em>Principal Author</em>); Ezana M. Azene, MD, PhD (<em>Research Author</em>); Bill S. Majdalany, MD (<em>Panel Vice-chair</em>); Ali F. AbuRahma, MD; Jeremy D. Collins, MD; Christopher J. Francois, MD; Marie D. Gerhard-Herman, MD; Heather L. Gornik, MD; John M. Moriarty, MB, BCh; Patrick T. Norton, MD; Thomas Ptak, MD, PhD; Stephen P. Reis, MD; Frank J. Rybicki, MD, PhD (<em>Specialty Chair</em>); Sanjeeva P. Kalva, MD (<em>Panel Chair</em>)</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Weiss C, Azene E, Rybicki FJ, Kim HS, Desjardins B, Fan CM, Flamm SD, Francois CJ, Gerhard-Herman MD, Kalva SP, Mansour MA, Mohler ER III, Oliva IB, Schenker MP, Expert Panel on Vascular Imaging. ACR Appropriateness Criteria&reg; sudden onset of cold, painful leg. [online publication]. Reston (VA): American College of Radiology (ACR); 2012. 6 p. [50 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f69338%2fNarrative%2f" title="ACR Web site">American College of Radiology (ACR) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>ACR Appropriateness Criteria&reg;. Overview. Reston (VA): American College of Radiology; 2015 Oct. 3 p. Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fOverview.pdf" title="ACR Web site">American College of Radiology (ACR) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Literature search process. Reston (VA): American College of Radiology; 2015 Feb. 1 p. Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fLiteratureSearchProcess.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Evidence table development. Reston (VA): American College of Radiology; 2015 Nov. 5 p. Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fEvidenceTableDevelopment.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Topic development process. Reston (VA): American College of Radiology; 2015 Nov. 2 p. Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fTopicDevelopmentProcess.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Rating round information. Reston (VA): American College of Radiology; 2015 Apr. 5 p. Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRatingRoundInfo.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Radiation dose assessment introduction. Reston (VA): American College of Radiology; 2015 Sep. 3 p. Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRadiationDoseAssessmentIntro.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Manual on contrast media. Reston (VA): American College of Radiology; 2016. 128 p. Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2fQuality-Safety%2fResources%2fContrast-Manual" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Procedure information. Reston (VA): American College of Radiology; 2016 May. 2 p. Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fE77E9964C8224151BE6D21A7CE68FEE4.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg; sudden onset of cold, painful leg. Evidence table. Reston (VA): American College of Radiology; 2016. 24 p. Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f69338%2fEvidenceTable%2f" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg; sudden onset of cold, painful leg. Literature search. Reston (VA): American College of Radiology; 2016. 2 p. Available from the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f69338%2fLitSearch%2f" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI on February 20, 2001. The information was verified by the guideline developer on March 14, 2001. This summary was updated by ECRI Institute on August 10, 2009. This summary was updated by ECRI Institute on December 17, 2010. This summary was updated by ECRI Institute on November 14, 2012. This summary was updated by ECRI Institute on September 29, 2016.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>Instructions for downloading, use, and reproduction of the American College of Radiology (ACR) Appropriateness Criteria&reg; may be found on the <a href="/web/20180713043816/https://www.guideline.gov/Home/Disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2fQuality-Safety%2fAppropriateness-Criteria%2fTermsConditions" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713043816im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180713043816/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180713043816/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180713043816/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180713043816/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180713043816/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180713043816/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180713043816/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713043816/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713043816/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713043816/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713043816/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713043816/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180713043816/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180713043816/https://www.guideline.gov/disclaimer?id=50430&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180713043816im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180713043816im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180713043816/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180713043816/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180713043816/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180713043816/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180713043816/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180713043816/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180713043816/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180713043816/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180713043816/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180713043816/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180713043816/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180713043816/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180713043816/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180713043816/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180713043816/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180713043816/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180713043816/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180713043816/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180713043816/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180713043816im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180713043816im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180713043816/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180713043816im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180713043816im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180713043816/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180713043816/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180713043816js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180713043816js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 04:38:16 Jul 13, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 16:43:19 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 125.935 (3)
  esindex: 0.011
  captures_list: 151.546
  CDXLines.iter: 19.553 (3)
  PetaboxLoader3.datanode: 72.234 (4)
  exclusion.robots: 0.313
  exclusion.robots.policy: 0.299
  RedisCDXSource: 0.917
  PetaboxLoader3.resolve: 827.661 (2)
  load_resource: 811.814
-->